253 Résultats de recherche pour
  • European Patent Office - coronavirus update

    Europe 18.03.2020
    In light of the ongoing coronavirus situation the EPO has issued guidance regarding its deadlines. Time periods expiring on or after the date of publication of their notice are extended for all parties...
  • Mediation in The Chancery Division

    Royaume-UniEcosse 16.03.2020
    The trouble with the progressive refinement of the rules for running commercial litigation, including the word “reforms”, is that whereas they are undoubtedly well – meant, in practice...
  • Disclosure Guidance in The Chancery Division

    Royaume-UniEcosse 16.03.2020
    Earlier this month, Vos J., the Chancellor, presided over a hearing where the parties had “sought guidance from the court by way of a discussion with the court in advance of… a case management...
  • Patenting Artificial Intelligence and quantum technologies

    Europe 28.02.2020
    IP and Life Science analysis: Caitlin Heard, IP Litigation Partner, and Rachel Free, Patent Attorney and Partner, at CMS UK, discuss the applicability of Artificial Intelligence (AI) and quantum technologies...
  • What you need to know about protecting your IP at MWC

    Espagne 10.02.2020
    Intellectual Property Fast Action Protocol Five years ago, Barcelona’s Commercial Courts (“the Courts”), and lately the European Union Trade Mark and Community Design Court of Alicante,...
  • A Short Guide: Priority Entitlement at the EPO

    Europe 31.01.2020
    Article 87 EPC Priority right (1) Any person who has duly filed, in or for (a) any State party to the Paris Convention for the Protection of Industrial Property or (b) any Member of the World Trade Organization,...
  • Can newly discovered cannabis compounds be protected by patents?

    Europe 15.01.2020
    A breakthrough discovery has recently hit the news: tetrahydrocannabiphorol (THCP) and cannabidiphorol (CBDP), two new cannabinoid compounds, have been discovered in Cannabis sativa and characterised for...
  • ‘Darunavir’ CJEU referral withdrawn - Article 3(a) of the SPC Regulation

    Europe 20.12.2019
    At the end of September, we reported here on the publication of AG Hogan’s Opinion on the joint referrals from the German Bundespatentgericht (case C-650/17) for Merck’s sitagliptin product...
  • The rise of patent wars in Europe’s gene therapy space

    Europe 17.12.2019
    The gene therapy industry is in an exciting phase of growth, undergoing significant M&A activity, product sales and new marketing authorisations that are being issued with increasing regularity globally....
  • UK Supreme Court's decision in Challenge to Arbitration of Global FRAND Terms

    Royaume-UniEcosse 16.12.2019
    On 21 October the UK Supreme Court started to consider whether an English court has the jurisdiction to settle the terms worldwide, not just for the UK, of a FRAND licence of Standard Essential Patents....